Cholinergic stimulation with pyridostigmine prevents the impairment in ventricular function during mental stress in coronary artery disease patients

International Journal of Cardiology

Volumn 125, Issue 3, 2008, Pages 418-421

  Nobrega, Antonio C L ^a   Loures, Debora L ^a   Pontes, Paulo V ^a   Sant'Anna, Isis D ^a   Mesquita, Evandro T ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Autonomic; Ejection fraction; Parasympathetic; Vagal; Ventricular contractility

Indexed keywords

PLACEBO; PYRIDOSTIGMINE;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIAC PATIENT; CHOLINERGIC STIMULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DIASTOLE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HEMODYNAMICS; HUMAN; LOW DRUG DOSE; MALE; MENTAL STRESS; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT RESPONSE;

CHOLINESTERASE INHIBITORS; CORONARY ARTERY DISEASE; CROSS-OVER STUDIES; DIASTOLE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRIDOSTIGMINE BROMIDE; STRESS, PSYCHOLOGICAL; STROKE VOLUME; VENTRICULAR DYSFUNCTION;

EID: 41049084322     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.01.043     Document Type: Article

References (22)

1. Herd J.A. Cardiovascular responses to stress. Physiol Rev 71 (1991) 305-330
2. James P.R., Taggart P., McNally S.T., Newman S.P., Sproton S.C., and Hardman S.M. Acute psychological stress and the propensity to ventricular arrhythmias: evidence for a linking mechanism. Am Heart J 21 (2000) 1023-1028
3. Strike P.C., Magid K., Brydon L., Edwards S., McEwan J.R., and Steptoe A. Exaggerated platelet and hemodynamic reactivity to mental stress in men with coronary artery disease. Psychosom Med 66 (2004) 492-500
4. Jiang W., Babyak M., Krantz D.S., et al. Mental stress-induced myocardial ischemia and cardiac events. JAMA 275 (1996) 1651-1656
5. Arrighi J.A., Burg M., Cohen I.S., and Soufer R. Simultaneous assessment of myocardial perfusion and function during mental stress in patients with chronic coronary artery disease. J Nucl Cardiol 10 (2003) 267-274
6. Sheps D.S., McMahon R.P., Becker L., et al. Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: results from the Psychophysiological Investigations of Myocardial Ischemia study. Circulation 105 (2002) 1780-1784
7. Bairey C.N., Krantz D.S., DeQuattro V., Berman D.S., and Rozanski A. Effect of beta-blockade on low heart-rate-related ischemia during mental stress. J Am Coll Cardiol 17 (1991) 1388-1395
8. Taylor P. Anticholinesterasis agents. In: Hardman J.G., and Limbird L.E. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th edition (1996), McGraw-Hill, New York, NY
9. Pearlman A.S., Gardin J.M., Martin R.P., et al. Guidelines for optimal physician training in echocardiography. Recommendations of the American Society of Echocardiography Committee for Physician Training in Echocardiography. Am J Cardiol 60 (1987) 158-163
10. Steptoe A., and Vogele C. Methodology of mental stress testing in cardiovascular research. Circulation 83 suppl II (1991) II-14-II-24
11. Schöder H., Silverman D.H., Campisi R., et al. Regulation of myocardial blood flow response to mental stress in healthy individuals. Am J Physiol Heart Circ Physiol 278 (2000) H360-H366
12. Peix A., Trapaga A., Asen L., et al. Mental stress-induced myocardial ischemia in women with angina and normal coronary angiograms. J Nucl Cardiol 13 (2006) 507-513
13. Spieker L.E., Hurlimann D., Ruschitzka F., et al. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation 105 (2002) 2817-2820
14. Furchgott R.F., and Zawadzki J.V. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Science 288 (1980) 373-376
15. Paulus W.J., and Shah A.M. NO and cardiac diastolic function. Cardiovasc Res 43 (1999) 595-606
16. Nobrega A.C., Carvalho A.C., Santos K.B., and Soares P.P. Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress. Clin Auton Res 9 (1999) 11-16
17. Behling A., Moraes R.S., Rohde L.E., Ferlin E.L., Nobrega A.C., and Ribeiro J.P. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. Am Heart J 146 (2003) 494-500
18. Castro R.R., Porphirio G., Serra S.M., and Nobrega A.C. Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease. Braz J Med Biol Res 35 (2002) 685-689
19. Castro R.R., Serra S.M., Porphirio G., Mendes F.S., Oliveira L.P., and Nobrega A.C. Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease. Int J Cardiol 107 (2006) 138-139
20. Sneddon J.F., Bashir Y., and Ward D.E. Vagal stimulation after myocardial infarction: accentuating the positive. J Am Coll Cardiol 22 (1993) 1335-1337
21. Castro R.R.T., Porphirio G., Serra S.M., and Nobrega A.C.L. Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia. Heart 90 (2004) 1119-1123
22. Nobrega A.C.L., and Castro R.R.T. Parasympathetic dysfunction as risk factor in myocardial infarction: what is the treatment?. Am Heart J 140 (2000) E-23